Vitiligo is caused by the destruction of melanocytes, the cells responsible for producing skin pigment. In most cases, the immune system mistakenly attacks and kills these cells, creating patches of skin that lose their color. The condition affects roughly 0.5% to 1% of the global population, and while it can appear at any age, it often starts before age 30.
The full picture is more complex than a single cause. Vitiligo develops through a combination of genetic vulnerability, immune system malfunction, oxidative stress inside the skin cells, and environmental triggers that can set the whole process in motion.
The Immune System Attacks Pigment Cells
The primary driver of vitiligo is autoimmune. Your immune system, which normally targets viruses and bacteria, turns against your own melanocytes instead. A specific type of white blood cell, called a CD8+ T cell, accumulates in the skin and directly destroys the pigment-producing cells. This is not a vague immune “imbalance.” It is a targeted attack, and the chemical signals that guide it are increasingly well understood.
The process works through a signaling chain. Immune cells in vitiligo skin release large amounts of a protein called interferon-gamma, which triggers surrounding skin cells to produce chemical signals that recruit even more immune cells to the area. This creates a feedback loop: the more immune cells arrive, the more signals get released, and the more melanocytes are destroyed. Research in mouse models has confirmed this signaling chain is critical for both the spread and persistence of white patches.
The surrounding skin cells (keratinocytes) can also suffer collateral damage. Inflammatory proteins in the affected area, including interferon-gamma, can sensitize these cells to die off as well, which helps explain why vitiligo patches sometimes have slightly different texture in addition to lost color.
Genetics Load the Gun
Vitiligo runs in families, though not in a simple, predictable pattern. Having a close relative with vitiligo raises your risk, but most people with the condition have no family history at all. Genome-wide studies have identified dozens of genes linked to vitiligo susceptibility, and nearly all of them play roles in immune function rather than pigment production itself.
Several of the most important genes control how immune cells communicate and activate. Some regulate T cell signaling, determining how aggressively your immune system responds to perceived threats. Others are involved in antigen presentation, the process by which cells flag molecules as “self” or “foreign.” When these systems carry certain variants, the threshold for attacking your own melanocytes drops. Additional genes linked to vitiligo help regulate immune cell migration, B cell development, and the function of regulatory T cells, which normally act as brakes on the immune response. When those brakes are weaker, autoimmune reactions are more likely to spiral.
Some of the same gene variants associated with vitiligo also appear in other autoimmune conditions, which helps explain why vitiligo frequently overlaps with diseases like thyroid disorders and type 1 diabetes.
Oxidative Stress Damages Cells From Within
Before the immune system even gets involved, something has to stress the melanocytes enough to make them visible targets. That “something” is often oxidative stress, an imbalance between harmful reactive molecules (especially hydrogen peroxide) and the cell’s ability to neutralize them.
Melanocytes are inherently vulnerable to oxidative damage because the process of making pigment itself generates reactive oxygen species. In people with vitiligo, the antioxidant defenses inside these cells appear to be weaker. Hydrogen peroxide accumulates, damages the cells’ internal machinery (particularly mitochondria, the energy-producing structures), and can push melanocytes toward programmed cell death. This cellular distress also releases molecular “danger signals” that catch the attention of the immune system, essentially waving a flag that says something is wrong. The immune system then responds, sometimes excessively, and the autoimmune cycle begins.
Chemicals and Physical Trauma as Triggers
For someone who is genetically predisposed, external factors can tip the balance. Chemical exposure is one of the most well-documented triggers. Certain phenol-based compounds, found in household cleaning products, hair dyes, rubber goods, and some industrial chemicals, can directly damage melanocytes. In one study of patients with chemical-triggered vitiligo, nearly 95% had been exposed to household chemicals, and about 65% developed their first patches at the same body site where the chemical contact occurred. These external oxidants can both initiate depigmentation and accelerate the progression of existing vitiligo.
Physical injury to the skin is another recognized trigger. Known as the Koebner phenomenon, this is when new vitiligo patches appear at sites of cuts, burns, scratches, tattoos, or even friction from tight clothing. Any injury that penetrates the top and middle layers of skin can provoke it, and new patches typically appear within 10 to 20 days of the injury. The resulting spots tend to follow the shape of the wound, often appearing in a straight line. Sunburn can also trigger this response, though it’s less common than mechanical injury.
Two Types With Different Mechanisms
Not all vitiligo works the same way. The most common form, non-segmental vitiligo, is the autoimmune-driven type described above. It tends to appear symmetrically on both sides of the body, often on the hands, face, and areas around body openings. It can spread over time and frequently follows a relapsing course.
Segmental vitiligo is less common and behaves differently. It typically appears on one side of the body in a band-like pattern, spreads for a limited period, and then stabilizes. Rather than being driven by immune cells, segmental vitiligo is thought to result from toxic chemicals released by nerve endings in the skin, which poison nearby melanocytes. This is why it tends to follow the distribution of a single nerve segment and rarely crosses the midline of the body.
Connection to Other Autoimmune Conditions
Because vitiligo shares genetic roots with other autoimmune diseases, it frequently co-occurs with them. Thyroid disorders are the most common overlap. A meta-analysis pooling data from dozens of studies found that about 6% of vitiligo patients have subclinical hypothyroidism (an underactive thyroid that hasn’t yet caused obvious symptoms), while about 3% have overt hypothyroidism and 2% have hyperthyroidism. Hashimoto’s thyroiditis, an autoimmune attack on the thyroid gland, appears in roughly 2% of vitiligo patients.
Other conditions that show up more often in people with vitiligo include alopecia areata (patchy hair loss), type 1 diabetes, pernicious anemia, and rheumatoid arthritis. This doesn’t mean having vitiligo guarantees you’ll develop another autoimmune disease, but the shared genetic wiring makes screening for thyroid function particularly worthwhile if you’ve been diagnosed.
Why It Spreads in Some People and Not Others
One of the most frustrating aspects of vitiligo is its unpredictability. Some people develop a single small patch that never changes. Others experience rapid spread across large areas of the body. The difference likely comes down to how many risk factors are stacking up at once: the strength of the genetic predisposition, the level of oxidative stress in the skin, ongoing chemical or physical triggers, and how aggressive the immune feedback loop becomes.
Emotional stress is frequently cited as a trigger by patients, and while the biological mechanism is harder to pin down than chemical exposure or skin injury, stress hormones can modulate immune function in ways that could plausibly worsen autoimmune activity. The interaction between all these factors, rather than any single cause, determines how vitiligo behaves in each individual.